Literature DB >> 9367228

Morphological evidence of ototoxicity of the iron chelator deferoxamine.

B Ryals1, E Westbrook, J Schacht.   

Abstract

Recent reports of the role of iron-catalyzed free radical formation in gentamicin ototoxicity and the successful attenuation of gentamicin ototoxicity by iron chelators led us to re-examine experimental material from a previously unpublished study of deferoxamine. Deferoxamine was injected i.m. into adult Japanese quail at either 300 or 750 mg/kg body weight for 30 days. Examination of sections from the basilar papilla at the light microscope level indicated that supporting cells were damaged after the lower drug dose, and that both supporting cells and hair cells were damaged after the higher drug dose. High, prolonged exposure to deferoxamine produced pathological changes similar to those seen in the basilar papilla after much lower, shorter doses of gentamicin. These results demonstrate that deferoxamine damages the quail inner ear and are consistent with the idea that the ototoxic actions of gentamicin may be mediated by iron chelation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9367228     DOI: 10.1016/s0378-5955(97)00094-4

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  8 in total

Review 1.  New developments in aminoglycoside therapy and ototoxicity.

Authors:  Jing Xie; Andra E Talaska; Jochen Schacht
Journal:  Hear Res       Date:  2011-05-27       Impact factor: 3.208

2.  Relationship between serum ferritin level and amikacin ototoxicity.

Authors:  Mohammad Shayaninasab; Mohammadreza Fatololoomi; Fatollah Behnood; Azam Alizamir
Journal:  Oman Med J       Date:  2012-07

3.  Frequency of sensory neural hearing loss in major Beta-thalassemias in southern iran.

Authors:  Abolhassan Faramarzi; Mehran Karimi; Seyed-Taghi Heydari; Mahmoud Shishegar; Masoud Kaviani
Journal:  Iran J Pediatr       Date:  2010-09       Impact factor: 0.364

4.  Coenzyme Q10 protects hair cells against aminoglycoside.

Authors:  Kazuma Sugahara; Yoshinobu Hirose; Takefumi Mikuriya; Makoto Hashimoto; Eiju Kanagawa; Hirotaka Hara; Hiroaki Shimogori; Hiroshi Yamashita
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

5.  New Advances in Evaluation of Hearing in a Sample of Egyptian Children with β-Thalassemia Major.

Authors:  Fatma A Alzaree; Manal A Shehata; Mohamed Abdel Atti; Gihan A Elzaree; Ghada M El-Kassas
Journal:  Open Access Maced J Med Sci       Date:  2019-05-15

6.  Liproxstatin-1 Protects Hair Cell-Like HEI-OC1 Cells and Cochlear Hair Cells against Neomycin Ototoxicity.

Authors:  Zhiwei Zheng; Dongmei Tang; Liping Zhao; Wen Li; Jinghong Han; Bing Hu; Guohui Nie; Yingzi He
Journal:  Oxid Med Cell Longev       Date:  2020-12-01       Impact factor: 6.543

7.  Protective Effects of Deferoxamine on Vestibulotoxicity in Gentamicin-Induced Bilateral Vestibulopathy Rat Model.

Authors:  Hyo-Jung Kim; Jin-Ok Lee; Ji-Soo Kim
Journal:  Front Neurol       Date:  2021-03-24       Impact factor: 4.003

Review 8.  Ferroptosis in Cardiovascular Diseases: Current Status, Challenges, and Future Perspectives.

Authors:  Yi Guo; Chanjun Lu; Ke Hu; Chuanqi Cai; Weici Wang
Journal:  Biomolecules       Date:  2022-03-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.